Maternal hormonal contraceptive use and offspring overweight or obesity

被引:6
|
作者
Jensen, E. T. [1 ,2 ]
Daniels, J. L. [2 ]
Stuermer, T. [2 ]
Robinson, W. R. [2 ]
Williams, C. J. [1 ]
Moster, D. [3 ]
Juliusson, P. B. [4 ]
Vejrup, K. [5 ]
Magnus, P. [5 ]
Longnecker, M. P. [1 ]
机构
[1] Natl Inst Environm Hlth Sci, Dept Epidemiol, NIH, Res Triangle Pk, NC 27709 USA
[2] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Epidemiol, Chapel Hill, NC USA
[3] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway
[4] Univ Bergen, Dept Clin Sci, Bergen, Norway
[5] Natl Inst Publ Hlth, Div Epidemiol, Oslo, Norway
基金
美国国家卫生研究院;
关键词
ORAL-CONTRACEPTIVES; BIRTH-WEIGHT; RISK-FACTORS; EXPOSURE; METABOLISM; PREGNANCY; CHILDHOOD; SEX; PROGESTERONE; PREVALENCE;
D O I
10.1038/ijo.2014.114
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND/OBJECTIVES: Experiments in animal models have shown a positive association between in utero exposure to pharmacologic sex hormones and offspring obesity. The developmental effects of such hormones on human obesity are unknown. SUBJECTS/METHODS: Using data from a large, prospective pregnancy cohort study (n = 19 652), with linkage to a national prescription registry, we evaluated the association between use of hormonal contraceptives before and after conception (defined from dispensed prescription data and characterized by last date of use relative to conception, 12 to >4 months before (n = 3392), 4 to >1 months before (n = 2541), 1 to >0 months before (n = 2997) and 0-12 weeks after (n = 567)) in relation to offspring overweight or obesity at age 3 years. RESULTS: We observed a weak, inverse association between early pregnancy use of a combination oral contraceptive and offspring overweight or obesity at age 3 (adjusted odds ratio (OR): 0.75, 95% confidence interval (CI): 0.53, 1.08) and a positive, but imprecise, association with use of a progestin-only oral contraceptive in early pregnancy (adjusted OR: 1.26, 95% CI: 0.79, 2.02). In general, no association was observed between the use of a hormonal contraceptive before conception and offspring overweight or obesity. A sensitivity analysis comparing combination oral contraceptive users in early pregnancy to other unplanned pregnancies without hormonal contraceptive use further strengthened the inverse association (adjusted OR: 0.70, 95% CI: 0.48, 1.02). Other sensitivity analyses were conducted to evaluate the robustness of the associations observed given varying assumptions. CONCLUSIONS: Pharmacologic sex hormones in early pregnancy may be inversely or positively associated with offspring overweight or obesity at age 3, depending on the specific formulation used. The present study provides support for the potential for environmental sources of hormonally active agents to exert developmental effects.
引用
收藏
页码:1275 / 1281
页数:7
相关论文
共 50 条
  • [1] Maternal hormonal contraceptive use and offspring overweight or obesity
    E T Jensen
    J L Daniels
    T Stürmer
    W R Robinson
    C J Williams
    D Moster
    P B Juliusson
    K Vejrup
    P Magnus
    M P Longnecker
    International Journal of Obesity, 2014, 38 : 1275 - 1281
  • [2] Maternal use of hormonal contraception and epilepsy in offspring
    Halane, H. I. M.
    Hargreave, M.
    Kjaer, S. K.
    Christensen, J.
    Morch, L. S.
    HUMAN REPRODUCTION, 2021, 36 (06) : 1674 - 1681
  • [3] Maternal overweight and obesity and risk of congenital heart defects in offspring
    J Brite
    S K Laughon
    J Troendle
    J Mills
    International Journal of Obesity, 2014, 38 : 878 - 882
  • [4] Maternal overweight and obesity and risk of congenital heart defects in offspring
    Brite, J.
    Laughon, S. k
    Troendle, J.
    Mills, J.
    INTERNATIONAL JOURNAL OF OBESITY, 2014, 38 (06) : 878 - 882
  • [5] Maternal oral contraceptive use and atopic diseases in the offspring
    Frye, C
    Mueller, JE
    Niedermeier, K
    Wjst, M
    Heinrich, J
    ALLERGY, 2003, 58 (03) : 229 - 232
  • [6] Erratum: Maternal overweight and obesity and risk of congenital heart defects in offspring
    J Brite
    S K Laughon
    J Troendle
    J Mills
    International Journal of Obesity, 2014, 38 (6) : 886 - 886
  • [7] Maternal gestational weight gain and offspring risk for childhood overweight or obesity
    Sridhar, Sneha B.
    Darbinian, Jeanne
    Ehrlich, Samantha F.
    Markman, Margot A.
    Gunderson, Erica P.
    Ferrara, Assiamira
    Hedderson, Monique M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 211 (03)
  • [8] Maternal Contraceptive Use and Central Nervous System Tumors in Offspring
    Spector, Logan G.
    Moertel, Christopher L.
    Su, H. Irene
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (01): : 39 - 40
  • [9] Obesity and hormonal contraceptive efficacy
    Robinson, Jennifer A.
    Burke, Anne E.
    WOMENS HEALTH, 2013, 9 (05) : 453 - 466
  • [10] Contraceptive Failures in Overweight and Obese Combined Hormonal Contraceptive Users
    Edelman, Alison
    Cherala, Ganesh
    Lim, Jeong Youn
    Jensen, Jeffrey T.
    OBSTETRICS AND GYNECOLOGY, 2013, 122 (01): : 158 - 159